Fosun Health to build first overseas hospitals in Indonesia amid Chinese ‘go global’ push


Fosun Health Group, a subsidiary of Fosun Pharmaceutical, said it plans to build its first overseas hospitals in Indonesia amid a push by Chinese healthcare companies to expand abroad.

The announcement underscores Indonesia’s appeal – home to the world’s fourth-largest population of 287 million – as Beijing encourages its healthcare sector to “go global”.

Fosun planned to establish “several hospitals” in Indonesia, CEO Frank Hu Hang told delegates at the South China Morning Post’s China Conference: Southeast Asia 2026, in Jakarta on Tuesday.

“We’ve signed term sheets with local partners, but not yet formally signed any contracts,” Hu told the SCMP. He did not disclose how many hospitals would be built or where they would be located.

Fosun was also exploring opportunities to work with local distributors to sell its products in Indonesia, as well as expanding cooperation with local manufacturers, he said.

Established in 2010, Shanghai-based Fosun Health Group operated 19 hospitals, clinics and third-party diagnostics centres in mainland China as of June 2025.

Fosun Health Group is a subsidiary of Fosun Pharmaceutical. Photo: Handout
Fosun Health Group is a subsidiary of Fosun Pharmaceutical. Photo: Handout
  • Related Posts

    Gold jumps nearly 2% as US-Iran peace deal weakens dollar, boosts bullion demand – Firstpost

    Gold prices climbed nearly 2 per cent to a one-week high after a US-Iran peace agreement weakened the dollar and sent oil prices sharply lower, easing inflation concerns and boosting…

    Continue reading
    Oil plunges 4% as markets cheer US-Iran agreement, bet on uninterrupted Hormuz traffic – Firstpost

    Asian stocks rallied and crude oil prices fell sharply after reports of a US-Iran peace agreement, easing concerns over energy supplies and inflation ahead of a crucial week of central…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *